CENEGERMIN BKBJ

N/A

Manufactured by Domp farmaceutici S.p.A.

28,659 FDA adverse event reports analyzed

Last updated: 2026-04-14

About CENEGERMIN BKBJ

CENEGERMIN BKBJ is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Domp farmaceutici S.p.A.. The most commonly reported adverse reactions for CENEGERMIN BKBJ include EYE PAIN, EYE IRRITATION, PRODUCT DOSE OMISSION ISSUE, OCULAR HYPERAEMIA, PHOTOPHOBIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CENEGERMIN BKBJ.

Top Adverse Reactions

EYE PAIN5,851 reports
EYE IRRITATION1,873 reports
PRODUCT DOSE OMISSION ISSUE1,338 reports
OCULAR HYPERAEMIA1,227 reports
PHOTOPHOBIA1,065 reports
VISION BLURRED945 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS902 reports
EYE SWELLING847 reports
OCULAR DISCOMFORT798 reports
LACRIMATION INCREASED737 reports
EYELID PAIN707 reports
HEADACHE673 reports
PRODUCT ADMINISTRATION ERROR614 reports
DRY EYE540 reports
OFF LABEL USE523 reports
DRUG INEFFECTIVE498 reports
FOREIGN BODY SENSATION IN EYES488 reports
THERAPY INTERRUPTED487 reports
PERIORBITAL PAIN477 reports
INTENTIONAL PRODUCT MISUSE347 reports
EYE DISCHARGE312 reports
ACCIDENTAL OVERDOSE294 reports
DEVICE USE ISSUE278 reports
VISUAL IMPAIRMENT278 reports
SWELLING OF EYELID254 reports
HOSPITALISATION247 reports
EYE PRURITUS209 reports
PRODUCT STORAGE ERROR200 reports
EYE INFLAMMATION191 reports
EYE INFECTION188 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION171 reports
EYELID IRRITATION166 reports
PRODUCT USE ISSUE164 reports
DEATH156 reports
PERIORBITAL SWELLING144 reports
DIZZINESS142 reports
PRODUCT USE COMPLAINT134 reports
TREATMENT NONCOMPLIANCE130 reports
FALL128 reports
ASTHENOPIA124 reports
RHINORRHOEA124 reports
ERYTHEMA OF EYELID116 reports
THERAPY PARTIAL RESPONDER113 reports
FACIAL PAIN107 reports
FATIGUE105 reports
CONDITION AGGRAVATED101 reports
COVID 1999 reports
MALAISE97 reports
NAUSEA97 reports
ILLNESS95 reports
PRODUCT DOSE OMISSION95 reports
PAIN93 reports
NASOPHARYNGITIS90 reports
TREATMENT DELAYED89 reports
URINARY TRACT INFECTION87 reports
ABNORMAL SENSATION IN EYE86 reports
EYELID MARGIN CRUSTING85 reports
WEIGHT DECREASED75 reports
COUGH73 reports
HYPERSENSITIVITY72 reports
PNEUMONIA67 reports
CORNEAL DEPOSITS66 reports
INTRAOCULAR PRESSURE INCREASED66 reports
DISEASE RECURRENCE65 reports
UNDERDOSE65 reports
OROPHARYNGEAL PAIN64 reports
EYE OPERATION63 reports
HORDEOLUM63 reports
RASH63 reports
MIGRAINE61 reports
SURGERY59 reports
SINUSITIS58 reports
HERPES ZOSTER57 reports
CORNEAL TRANSPLANT56 reports
SUPERFICIAL INJURY OF EYE51 reports
DISEASE PROGRESSION49 reports
INFLUENZA49 reports
DYSPNOEA46 reports
SOMNOLENCE46 reports
RHINALGIA45 reports
DIARRHOEA43 reports
SWELLING FACE43 reports
BLOOD PRESSURE INCREASED42 reports
PRURITUS42 reports
CEREBROVASCULAR ACCIDENT41 reports
EYE DISORDER41 reports
OVERDOSE40 reports
DRUG HYPERSENSITIVITY39 reports
VITREOUS FLOATERS39 reports
INSOMNIA38 reports
CORNEAL ABRASION37 reports
VISUAL ACUITY REDUCED37 reports
ADVERSE EVENT36 reports
EYE ULCER36 reports
SLEEP DISORDER35 reports
EYE CONTUSION34 reports
SINUS DISORDER34 reports
ASTHENIA33 reports
NASAL CONGESTION32 reports
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE32 reports

Report Outcomes

Out of 11,957 classified reports for CENEGERMIN BKBJ:

Serious 11.7%Non-Serious 88.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female8,075 (70.0%)
Male3,457 (30.0%)
Unknown1 (0.0%)

Reports by Age

Age 75141 reports
Age 76131 reports
Age 69121 reports
Age 73116 reports
Age 72115 reports
Age 67113 reports
Age 68111 reports
Age 71109 reports
Age 77108 reports
Age 80107 reports
Age 82106 reports
Age 74105 reports
Age 78105 reports
Age 79105 reports
Age 70104 reports
Age 8197 reports
Age 6584 reports
Age 6381 reports
Age 6681 reports
Age 6077 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CENEGERMIN BKBJ?

This profile reflects 28,659 FDA FAERS reports that mention CENEGERMIN BKBJ. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CENEGERMIN BKBJ?

Frequently reported terms in FAERS include EYE PAIN, EYE IRRITATION, PRODUCT DOSE OMISSION ISSUE, OCULAR HYPERAEMIA, PHOTOPHOBIA, VISION BLURRED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CENEGERMIN BKBJ?

Labeling and FAERS entries often list Domp farmaceutici S.p.A. in connection with CENEGERMIN BKBJ. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.